TELL : +91 0 99 08 87 07 06

 Mcmed International ®: Largest Journal Publication in world

Acta Biomedica Scientia

Volume 4, Issue 3, 2017
Mcmed International
Acta Biomedica Scientia
Issn
2348 - 215X (Print), 2348 - 2168 (Online)
Frequency
bi-annual
Email
editorabs@mcmed.us
Journal Home page
http://mcmed.us/journal/abs
Recommend to
A Friend  | A librarian
Purchase
Purchase Issue
Abstract
Title
STUDY OF VARIOUS PATHWAYS OF EMERGENCY AUTHORIZATION OF CORONA MEDICATIONS BY VARIOUS REGULATORY AGENCIES AROUND IN THE WORLD
Author
Peethala Harshini1, Avinash Kumar G2*, Manasa E2, Divya E
Email
dravinashreddy88@gmail.com
keyword
COVID-19, WHO, public health, Emergency Use Authorization, FDA
Abstract
The World Health Organization (WHO) has been leading the global response to COVID-19 by monitoring the virus's spread, facilitating international information exchange, and providing technical support to countries. As of April 30, 2020, COVID-19 had reached 212 countries, causing over 3 million cases and 211,028 deaths. Effective public health measures and surveillance are crucial for managing such health crises. WHO is analyzing COVID-19 data in relation to country readiness to identify gaps in the current public health system. The majority of Emergency Use Authorizations (EUAs) for COVID-19 diagnostics were based on preliminary data, raising concerns about their accuracy and reliability. The FDA must balance the need for rapid adoption of new technologies with ensuring safety and efficacy. This study highlights the need for improved evidence standards for EUAs in future public health emergencies
Download Broucher
Back to Top >>>>